Everything tagged "turnaround" across the TickerSpark archives.
Lincoln National is emerging as a credible turnaround, with improving operating earnings across annuities, life, and group protection. The stock screens cheap, but negative free cash flow and market-sensitive results keep it in value-recovery territory.
Fresenius Medical Care posted a sharp 2025 profitability step-up, but 2026 is a transition year as temporary benefits roll off and rollout costs rise. The stock looks like a measured Buy for investors willing to wait for execution to stick.
Westlake is a medium-term cyclical turnaround story with a resilient housing/infrastructure segment offsetting weak chemicals. Management’s 2026 EBITDA improvement plan and capacity rationalization support a constructive Buy view.
FedEx is showing faster-than-expected improvement in its core parcel and express business as Network 2.0, pricing, and mix drive margin expansion. The upcoming FedEx Freight spin-off should further simplify the story, though valuation and leverage still limit the upside.
Clorox rebuilt profitability in fiscal 2025, but FY2026 guidance was cut sharply as ERP-related inventory drawdown hit sales and margins. The stock looks like a steady staples franchise in repair, with valuation close to fair and upside tied to execution.
Super Micro Computer is scaling rapidly on AI infrastructure demand, but execution, margins, and customer concentration remain key risks. The stock looks inexpensive versus its forward earnings power if management can stabilize profitability.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime